increasingli difficult reinvest upsid
reiter hold rais pt ebitda
note risk/reward becom attract verisk seem pois
leas constant organ revenue growth better profit expect
on-going invest contend becom difficult keep
ebitda margin ex major strateg deal result valuat
could see upsid alert potenti entri point around materi
weak new rev/ebitda est
prior street
insur perform increasingli construct sustain
high-singl segment organ revenue growth demand seem
broaden addit grow row mostli uk footprint believ
insuretech startup use co solut data take share
tradit underwrit durabl demand question
risk verisk instal base contend tech develop key
aspect co l-t financi perform competit posit
regard verisk seem improv market stand better insur
perform inform faster organ revenue growth
margin lift outperform ytd vs despit
y/i ebitda margin declin attribut fx sbc time
margin flattish ex item stock premium valuat nonetheless
notabl opinion verisk continu invest constrain
margin outlook may pois chang howev absent strateg
believ co run area reinvest perhap set
faster ebitda growth aggress capit return factor
could make us bullish reflect higher
busi fine matter much maintain investor
insur effect toler fi
improv especi fi ebitda neither seem
strateg central doubt bod would consid would
like see verisk sell busi return capit longer see
need busi outsid insur although insur might
rel limit growth prospect year ago contend aerial
imag insuretech row expand result return capit
tighter focu could boost valuat lessen volatil distract
would bullish strateg shift
solid acceler insur fi
tr target
rais price target
boost price object would trade ebitda estim
level valuat would small discount stock current estim ebitda
estim state potenti faster ebitda growth could caus us revisit view
power scale merit premium realli matter degre
also base price object proprietari analysi project verisk drive
take estim next five year project
base follow assumpt five-year revenu compound-annual-growth-rate margin expand
flat invest capit
page
base proprietari analysi would command ev/ic multipl
assum investor demand annual equiti return hold impli equiti
valu one year today assum verisk gener annual averag
discount back rate yield addit valu
assert methodolog roughli support price target
page
total cost revenu
sell gener administr
depreci amort
realiz gain/ loss invest net
provis incom taxes/ benefit
thousand except per-shar
amort intang
total cost revenu
sell gener administr
oper margin tot revenu
pre-tax margin tot revenu
adjust net incom margin total revenu
ebitda margin revenu
free margin tot revenu
total cost revenu
depreci amort
compani report suntrust robinson humphrey estim
page
cash equival
feder foreign incom tax receiv
state local inom tax reciev
account payabl accru liabil
short-term debt current portion long-term
pension postretir benfit current
fee receiv advanc
thousand except per-shar
compani report suntrust robinson humphrey estim
page
provid data analyt inform profession insur healthcar
mortgag govern risk manag industri compani oper two segment
risk assess decis analyt risk assess segment serv property-casualty
insur industri help defin measur manag risk provid data softwar
inform servic global servic includ data statist servic actuari servic
standard insur polici program underwrit inform rating-integr tool
decis analyt segment provid custom solut help make inform decis
manag asset associ risk predict futur loss price risk detect prevent
fraud quantifi loss
verisk possess one best-differenti secular growth model univers compani
oper two busi segment high-barri risk assess segment faster-grow
decis analyt segment believ share warrant premium valuat due verisk strong
top-lin growth prospect opportun oper margin expans systemat balanc sheet de-
leverag manag commit return sharehold capit
valuat risk
price target would trade estim ebitda
longer term verisk valuat underpin view strong organ revenu growth like
long-term ebitda margin expans substanti entri barrier balanc sheet de-lever
howev near term ebitda margin pressur reinvest lack tangibl
organ revenu growth catalyst limit near term upsid opinion
upsid risk price target includ greater-than-expect acceler insur segment
organ revenu growth woodmac revenu growth may rebound faster forecast
downsid risk price target includ greater-than-expect ebitda margin headwind
driven continu intern invest acquisit integr impair abil acquir
extern data compani product deriv prolong downturn
insur industri disrupt chang mortgag industri vertic market consolid
and/or price pressur inabl develop new value-ad data analyt solut
result reduc demand compani product
andrew jeffrey herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
